Pfizer - PFE Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
News Sentiment
About
FAQ

Consensus Rating: Hold
Consensus Price Target: $36.88
Forecasted Upside: 41.83%
Number of Analysts: 17
Breakdown:
0 Sell Ratings
11 Hold Ratings
6 Buy Ratings
0 Strong Buy Ratings

^$26.00 As of 04/19/2024 01:00 AM ET

▲ +0.61 (2.40%)

1 month | 3 months | 12 months

Get New Pfizer Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for PFE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PFE

^$36.88

▲ +41.83% Upside Potential

This price target is based on 17 analysts offering 12 month price targets for Pfizer in the last 3 months. The average price target is $36.88, with a high forecast of $50.00 and a low forecast of $27.00. The average price target represents a 41.83% upside from the last price of $26.00.

Current Consensus is Hold

The current consensus among 17 polled investment analysts is to hold stock in Pfizer. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
6 buy ratings
11 hold ratings
0 sell ratings

Ratings as of

10/28/2022

0 strong buy ratings
6 buy ratings
11 hold ratings
0 sell ratings

Ratings as of

1/26/2023

0 strong buy ratings
6 buy ratings
11 hold ratings
0 sell ratings

Ratings as of

4/26/2023

0 strong buy ratings
6 buy ratings
11 hold ratings
0 sell ratings

Ratings as of

7/25/2023

0 strong buy ratings
6 buy ratings
11 hold ratings
0 sell ratings

Ratings as of

10/23/2023

0 strong buy ratings
6 buy ratings
11 hold ratings
0 sell ratings

Ratings as of

1/21/2024

0 strong buy ratings
6 buy ratings
11 hold ratings
0 sell ratings

Ratings as of

3/21/2024

0 strong buy ratings
6 buy ratings
11 hold ratings
0 sell ratings

Ratings as of

4/20/2024

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/15/2024	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$45.00	Low
4/1/2024	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$45.00	Low
3/22/2024	Argus	Downgrade	Buy ➝ Hold		Low
3/1/2024	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$45.00	Low
2/23/2024	Guggenheim	Initiated Coverage	Buy	$36.00	Low
1/31/2024	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$45.00	Low
1/9/2024	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$45.00	Low
1/4/2024	TD Cowen	Downgrade	Outperform ➝ Market Perform	$32.00	Low
12/18/2023	Cantor Fitzgerald	Reiterated Rating	Overweight		Low
12/14/2023	Truist Financial	Lower Target	Buy ➝ Buy	$42.00 ➝ $36.00	Low
12/14/2023	UBS Group	Lower Target	Neutral ➝ Neutral	$34.00 ➝ $27.00	Low
12/14/2023	Barclays	Lower Target	Equal Weight ➝ Equal Weight	$34.00 ➝ $28.00	Low
12/4/2023	Truist Financial	Reiterated Rating	Buy ➝ Buy	$42.00	Low
11/20/2023	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$75.00	Low
11/1/2023	Barclays	Lower Target	Equal Weight ➝ Equal Weight	$35.00 ➝ $34.00	Low
11/1/2023	Morgan Stanley	Lower Target	Equal Weight ➝ Equal Weight	$39.00 ➝ $37.00	Low
10/20/2023	UBS Group	Reiterated Rating	Neutral ➝ Neutral	$36.00 ➝ $34.00	Low
10/17/2023	Truist Financial	Lower Target	Buy ➝ Buy	$62.00 ➝ $42.00	Low
10/17/2023	Morgan Stanley	Lower Target	Equal Weight ➝ Equal Weight	$40.00 ➝ $39.00	Low
10/16/2023	BMO Capital Markets	Lower Target	Outperform ➝ Outperform	$44.00 ➝ $33.00	Low
10/16/2023	Citigroup	Lower Target	Neutral ➝ Neutral	$42.00 ➝ $35.00	Low
10/16/2023	JPMorgan Chase & Co.	Lower Target	Neutral ➝ Neutral	$36.00 ➝ $34.00	Low
10/16/2023	Wells Fargo & Company	Lower Target	Equal Weight ➝ Equal Weight	$39.00 ➝ $35.00	Low
10/16/2023	Jefferies Financial Group	Upgrade	Hold ➝ Buy	$38.00 ➝ $39.00	Low
10/6/2023	JPMorgan Chase & Co.	Lower Target	Neutral ➝ Neutral	$39.00 ➝ $36.00	Low
10/2/2023	Barclays	Lower Target		$38.00 ➝ $35.00	Low
10/2/2023	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$75.00	Low
9/18/2023	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$75.00	Low
9/13/2023	Truist Financial	Reiterated Rating	Buy ➝ Buy	$62.00	Low
9/5/2023	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$75.00	Low
8/30/2023	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$75.00	Low
8/22/2023	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$75.00	Low
8/2/2023	BMO Capital Markets	Lower Target	Outperform ➝ Outperform	$45.00 ➝ $44.00	Low
8/2/2023	Morgan Stanley	Lower Target	Equal Weight ➝ Equal Weight	$42.00 ➝ $40.00	N/A
8/2/2023	Truist Financial	Lower Target	Buy ➝ Buy	$64.00 ➝ $62.00	N/A
8/2/2023	Jefferies Financial Group	Lower Target		$40.00 ➝ $38.00	Low
7/21/2023	Morgan Stanley	Lower Target	Equal Weight	$43.00 ➝ $42.00	Low
7/18/2023	BMO Capital Markets	Lower Target		$49.00 ➝ $45.00	Low
7/17/2023	JPMorgan Chase & Co.	Lower Target	Neutral	$45.00 ➝ $41.00	Low
7/14/2023	HSBC	Initiated Coverage	Buy	$50.00	Low
7/11/2023	Barclays	Lower Target		$40.00 ➝ $38.00	Low
6/29/2023	Credit Suisse Group	Downgrade	Outperform ➝ Neutral	$47.00 ➝ $40.00	Low
5/17/2023	Cantor Fitzgerald	Reiterated Rating	Overweight		Low
5/11/2023	Daiwa Capital Markets	Downgrade	Outperform ➝ Neutral	$38.00	Low
5/5/2023	UBS Group	Lower Target		$41.00 ➝ $39.00	Low
5/3/2023	Barclays	Lower Target		$43.00 ➝ $40.00	Low
4/21/2023	Bank of America	Lower Target	Neutral	$50.00 ➝ $45.00	Low
4/12/2023	Barclays	Lower Target	Equal Weight	$44.00 ➝ $43.00	Low
4/10/2023	Morgan Stanley	Lower Target	Equal Weight	$45.00 ➝ $44.00	Low
3/17/2023	Wells Fargo & Company	Lower Target	Equal Weight	$50.00 ➝ $44.00	Low
3/14/2023	UBS Group	Set Target		$45.00	Low
3/6/2023	Jefferies Financial Group	Initiated Coverage	Hold	$43.00	Low
2/28/2023	UBS Group	Set Target		$45.00	Low
2/27/2023	JPMorgan Chase & Co.	Set Target		$45.00	Low
2/7/2023	Berenberg Bank	Set Target		$40.00	Low
2/7/2023	Daiwa Capital Markets	Upgrade	Neutral ➝ Outperform	$51.00	Low
2/1/2023	UBS Group	Set Target		$45.00	Low
2/1/2023	Morgan Stanley	Lower Target	Equal Weight	$53.00 ➝ $45.00	Low
2/1/2023	Cantor Fitzgerald	Reiterated Rating	Overweight	$75.00	Low
2/1/2023	SVB Leerink	Lower Target	Market Perform	$49.00 ➝ $48.00	Low
2/1/2023	Atlantic Securities	Lower Target	Neutral	$50.00 ➝ $46.00	Low
2/1/2023	BMO Capital Markets	Lower Target	Outperform	$55.00 ➝ $53.00	Low
2/1/2023	Credit Suisse Group	Lower Target	Outperform	$54.00 ➝ $50.00	Low
2/1/2023	Barclays	Lower Target	Equal Weight	$49.00 ➝ $44.00	Low
1/31/2023	JPMorgan Chase & Co.	Set Target		$50.00	Low
1/26/2023	UBS Group	Downgrade	Buy ➝ Neutral	$55.00 ➝ $47.00	Low
1/18/2023	UBS Group	Set Target		$55.00	Low
1/18/2023	Credit Suisse Group	Set Target		$54.00	Low
1/18/2023	JPMorgan Chase & Co.	Set Target		$50.00	Low
1/17/2023	Wells Fargo & Company	Downgrade	Overweight ➝ Equal Weight	$54.00 ➝ $50.00	Low
1/10/2023	JPMorgan Chase & Co.	Set Target		$50.00	Low
1/4/2023	Bank of America	Downgrade	Buy ➝ Neutral	$60.00	Low
12/14/2022	Morgan Stanley	Boost Target	Equal Weight	$51.00 ➝ $53.00	Low
12/13/2022	Credit Suisse Group	Set Target		$55.00	Low
12/13/2022	The Goldman Sachs Group	Upgrade	Neutral ➝ Buy	$47.00 ➝ $60.00	Low
12/6/2022	Credit Suisse Group	Set Target		$55.00	Low
11/23/2022	Credit Suisse Group	Set Target		$55.00	Low
11/17/2022	Credit Suisse Group	Initiated Coverage	Outperform	$55.00	Low
11/8/2022	The Goldman Sachs Group	Set Target		$47.00	Low
11/3/2022	SVB Leerink	Boost Target	Market Perform	$48.00 ➝ $49.00	Low
11/3/2022	UBS Group	Set Target		$55.00	Low
11/2/2022	Wells Fargo & Company	Lower Target	Overweight	$55.00 ➝ $54.00	Low
11/2/2022	Morgan Stanley	Boost Target	Equal Weight	$50.00 ➝ $51.00	Low
11/2/2022	Barclays	Boost Target	Equal Weight	$44.00 ➝ $49.00	Low
11/1/2022	JPMorgan Chase & Co.	Set Target		$50.00	Low
10/17/2022	The Goldman Sachs Group	Set Target		$48.00	Low
10/12/2022	Morgan Stanley	Boost Target	Equal Weight	$49.00 ➝ $50.00	Low
10/12/2022	Barclays	Lower Target	Equal Weight	$50.00 ➝ $44.00	Low
10/11/2022	JPMorgan Chase & Co.	Set Target		$50.00	Low
10/11/2022	SVB Leerink	Lower Target	Market Perform ➝ Market Perform	$53.00 ➝ $48.00	Low
9/14/2022	Berenberg Bank	Set Target		$44.00	Low
9/1/2022	The Goldman Sachs Group	Set Target		$50.00	Low
9/1/2022	UBS Group	Set Target		$59.00	Low
9/1/2022	Barclays	Set Target		$50.00	Low
8/26/2022	The Goldman Sachs Group	Set Target		$50.00	Low
8/26/2022	UBS Group	Set Target		$59.00	Low
8/26/2022	Barclays	Set Target		$50.00	Low
8/9/2022	Barclays	Boost Target		$52.00	Low
8/1/2022	Barclays	Boost Target	Equal Weight	$50.00 ➝ $52.00	Low
7/29/2022	The Goldman Sachs Group	Set Target		$50.00	Low
7/29/2022	SVB Leerink	Lower Target	Market Perform	$55.00 ➝ $53.00	Low
7/13/2022	The Goldman Sachs Group	Set Target		$51.00	Low
7/8/2022	Morgan Stanley	Lower Target	Equal Weight	$52.00 ➝ $49.00	N/A
7/7/2022	Barclays	Set Target		$52.00	N/A
6/28/2022	JPMorgan Chase & Co.	Set Target		$57.00	Low
6/27/2022	Barclays	Set Target		$52.00	Low
5/27/2022	Berenberg Bank	Set Target		$50.00	Low
5/25/2022	The Goldman Sachs Group	Set Target		$51.00	Low
5/23/2022	SVB Leerink	Initiated Coverage	Market Perform	$55.00	Low
5/19/2022	Berenberg Bank	Set Target		$50.00	High
5/17/2022	Barclays	Set Target		$52.00	Low
5/4/2022	Barclays	Set Target		$52.00	Medium
5/4/2022	The Goldman Sachs Group	Set Target		$51.00	Medium
5/4/2022	Wells Fargo & Company	Lower Target		$60.00 ➝ $55.00	Low
5/3/2022	JPMorgan Chase & Co.	Set Target		$57.00	Low
4/21/2022	Berenberg Bank	Set Target		$50.00	Medium
4/6/2022	Morgan Stanley	Initiated Coverage	Equal Weight	$55.00	Medium
4/5/2022	Citigroup	Boost Target	Neutral	$46.00 ➝ $57.00	N/A
2/10/2022	Morgan Stanley	Lower Target	Equal Weight	$60.00 ➝ $55.00	Medium
2/10/2022	Mizuho	Lower Target		$56.00 ➝ $55.00	Medium
2/9/2022	Barclays	Set Target		$54.00	Low
2/8/2022	JPMorgan Chase & Co.	Set Target		$57.00	Low
2/8/2022	The Goldman Sachs Group	Set Target	Neutral	$51.00 ➝ $54.00	Low
1/28/2022	JPMorgan Chase & Co.	Boost Target	Neutral	$53.00 ➝ $57.00	Low
1/14/2022	BMO Capital Markets	Boost Target		$60.00 ➝ $76.00	Low
1/11/2022	Barclays	Set Target		$54.00	Low
1/10/2022	The Goldman Sachs Group	Set Target		$51.00	Low
1/7/2022	Wells Fargo & Company	Boost Target	Overweight	$60.00 ➝ $65.00	Low
1/5/2022	Bank of America	Upgrade	Neutral ➝ Buy	$59.00 ➝ $70.00	Low
1/4/2022	The Goldman Sachs Group	Set Target		$51.00	High
1/4/2022	Barclays	Set Target		$54.00	High
1/3/2022	Sanford C. Bernstein	Boost Target	Market Perform	$44.00 ➝ $65.00	Medium
12/29/2021	The Goldman Sachs Group	Set Target		$51.00	High
12/29/2021	Barclays	Set Target		$54.00	High
12/23/2021	Barclays	Set Target		$54.00	High
12/23/2021	The Goldman Sachs Group	Set Target		$51.00	Medium
12/20/2021	Cowen	Boost Target	Outperform ➝ Outperform	$56.00 ➝ $70.00	Medium
12/17/2021	The Goldman Sachs Group	Initiated Coverage	Neutral	$51.00	High
12/16/2021	Barclays	Set Target		$54.00	High
12/15/2021	SVB Leerink	Boost Target	Market Perform	$52.00 ➝ $56.00	High
12/14/2021	Mizuho	Boost Target	Neutral ➝ Neutral	$44.00 ➝ $56.00	High
12/14/2021	Berenberg Bank	Reiterated Rating	Hold	$54.00	Medium
12/13/2021	JPMorgan Chase & Co.	Set Target		$53.00	Low
12/13/2021	UBS Group	Upgrade	Neutral ➝ Buy	$52.00 ➝ $60.00	High
12/10/2021	Barclays	Boost Target	Equal Weight ➝ Equal Weight	$44.00 ➝ $54.00	High
12/8/2021	Wells Fargo & Company	Initiated Coverage	Overweight	$60.00	Medium
11/29/2021	JPMorgan Chase & Co.	Boost Target	Neutral	$42.00 ➝ $53.00	High
11/29/2021	Morgan Stanley	Boost Target	Sell ➝ Equal Weight	$50.00 ➝ $60.00	High
11/24/2021	Truist Financial	Boost Target	Buy	$43.00 ➝ $58.00	Low
11/18/2021	BMO Capital Markets	Initiated Coverage	Outperform	$60.00	High
11/17/2021	Barclays	Set Target		$44.00	High
11/11/2021	Independent Research	Upgrade	Buy	$53.00	Low
11/5/2021	Cantor Fitzgerald	Reiterated Rating	Buy	$60.00	Low
11/5/2021	Benchmark	Boost Target	Buy	$29.00 ➝ $45.00	Low
11/5/2021	JPMorgan Chase & Co.	Set Target		$42.00	High
11/3/2021	Barclays	Set Target		$44.00	Medium
11/3/2021	SVB Leerink	Lower Target	Market Perform	$50.00 ➝ $48.00	High
10/12/2021	Morgan Stanley	Boost Target	Equal Weight	$45.00 ➝ $48.00	Low
10/3/2021	Mizuho	Reiterated Rating	Hold	$43.00	Medium
9/20/2021	SVB Leerink	Boost Target	Market Perform	$49.00 ➝ $50.00	High
9/14/2021	SVB Leerink	Reiterated Rating	Hold	$49.00	Low
9/13/2021	JPMorgan Chase & Co.	Boost Target	Neutral	$40.00 ➝ $42.00	High
7/30/2021	Mizuho	Boost Target	Neutral	$42.00 ➝ $43.00	Low
7/29/2021	The Goldman Sachs Group	Set Target		$48.00	Low
7/29/2021	Morgan Stanley	Boost Target	Equal Weight	$42.00 ➝ $45.00	Low
7/29/2021	Royal Bank of Canada	Set Target		$44.00	Low
7/29/2021	SVB Leerink	Boost Target	Market Perform	$47.00 ➝ $49.00	Low
7/27/2021	Truist Financial	Initiated Coverage	Buy	$43.00	High
6/17/2021	Royal Bank of Canada	Boost Target	Sector Perform	$43.00 ➝ $44.00	Low
6/15/2021	Berenberg Bank	Reiterated Rating	Neutral	$43.00	Low
5/24/2021	JPMorgan Chase & Co.	Set Target	Neutral	$40.00	Low
5/24/2021	The Goldman Sachs Group	Set Target	Neutral	$45.00	Low
5/13/2021	The Goldman Sachs Group	Reiterated Rating	Neutral	$45.11	Low
5/12/2021	Mizuho	Reiterated Rating	Buy ➝ Neutral	$42.00	Low
5/10/2021	Morgan Stanley	Boost Target	Equal Weight	$38.00 ➝ $42.00	Low
5/6/2021	Mizuho	Downgrade	Buy ➝ Neutral	$42.00	Low
5/5/2021	SVB Leerink	Boost Target	Market Perform	$39.00 ➝ $43.00	High
5/5/2021	JPMorgan Chase & Co.	Boost Target	Neutral	$36.00 ➝ $40.00	Medium
5/5/2021	Barclays	Boost Target	Equal Weight	$37.00 ➝ $40.00	Medium
4/7/2021	Royal Bank of Canada	Initiated Coverage	Sector Perform	$42.00	Low
4/6/2021	The Goldman Sachs Group	Set Target	Neutral	$41.00	Low
3/31/2021	The Goldman Sachs Group	Set Target	Neutral	$41.00	Low
3/26/2021	SVB Leerink	Lower Target	Market Perform	$40.00 ➝ $39.00	Medium
3/23/2021	Berenberg Bank	Reiterated Rating	Neutral	$38.00	Medium
3/15/2021	The Goldman Sachs Group	Set Target	Neutral	$41.00	Medium
3/9/2021	The Goldman Sachs Group	Reiterated Rating	Neutral	$41.00	Low
2/3/2021	JPMorgan Chase & Co.	Set Target	Neutral	$36.00	Low
2/3/2021	DZ Bank	Reiterated Rating	Hold ➝ Buy	$41.00	Low
2/3/2021	SVB Leerink	Lower Target	Market Perform	$44.00 ➝ $40.00	Low
2/3/2021	Mizuho	Lower Target	Buy	$44.00 ➝ $42.00	Low
1/29/2021	Morgan Stanley	Lower Target	Equal Weight	$40.00 ➝ $38.00	Medium
1/21/2021	The Goldman Sachs Group	Set Target	Neutral	$40.00	Low
1/8/2021	The Goldman Sachs Group	Set Target	Neutral	$40.00	Low
1/4/2021	Royal Bank of Canada	Set Target	Neutral	$42.00	N/A
12/29/2020	Royal Bank of Canada	Reiterated Rating	Neutral	$42.00	N/A
12/16/2020	Royal Bank of Canada	Downgrade	Outperform ➝ Sector Perform	$43.00 ➝ $42.00	N/A
12/11/2020	The Goldman Sachs Group	Set Target	Neutral	$40.00	Low
12/4/2020	Barclays	Boost Target	Equal Weight	$35.00 ➝ $37.00	Low
12/2/2020	Barclays	Set Target	Neutral	$35.00	Medium
12/2/2020	Royal Bank of Canada	Set Target	Buy	$43.00	Low
12/2/2020	The Goldman Sachs Group	Set Target	Neutral	$40.00	Low
11/19/2020	The Goldman Sachs Group	Initiated Coverage	Neutral	$40.00	Medium
11/10/2020	Sanford C. Bernstein	Initiated Coverage	Market Perform	$42.00	High
11/10/2020	Mizuho	Boost Target	Buy	$43.00 ➝ $44.00	High
11/9/2020	Barclays	Reiterated Rating	Neutral	$35.00	High
11/9/2020	JPMorgan Chase & Co.	Set Target	Neutral	$36.00	High
10/28/2020	SVB Leerink	Boost Target	Market Perform	$42.00 ➝ $43.00	High
10/23/2020	Truist Financial	Initiated Coverage	Buy	$42.00	Low
10/16/2020	Royal Bank of Canada	Set Target	Buy	$43.00	Low
10/12/2020	Atlantic Securities	Downgrade	Overweight ➝ Neutral	$44.00 ➝ $39.00	Low
9/29/2020	Berenberg Bank	Initiated Coverage	Hold	$38.00	Low
9/15/2020	Mizuho	Reiterated Rating	Buy	$43.00	Low
9/9/2020	Royal Bank of Canada	Set Target	Buy	$43.00	Low
7/30/2020	Morgan Stanley	Boost Target	Equal Weight	$36.00 ➝ $42.00	Low
7/29/2020	UBS Group	Boost Target	Neutral	$37.00 ➝ $39.00	Low
7/29/2020	SVB Leerink	Boost Target	Market Perform	$39.00 ➝ $42.00	Low
7/28/2020	Mizuho	Reiterated Rating	Positive ➝ Buy	$38.00	Low
7/21/2020	Morgan Stanley	Reiterated Rating	Hold	$36.00	High
7/20/2020	Royal Bank of Canada	Reiterated Rating	Buy	$43.00	High
6/29/2020	Mizuho	Initiated Coverage	Buy	$38.00	Low
6/26/2020	Piper Sandler	Boost Target		$18.50 ➝ $24.00	Medium
6/16/2020	SVB Leerink	Initiated Coverage	Market Perform	$40.00	Low
6/1/2020	Barclays	Lower Target		$37.00 ➝ $35.00	Medium
6/1/2020	JPMorgan Chase & Co.	Lower Target	Neutral	$37.00 ➝ $36.00	High
5/18/2020	Mizuho	Reiterated Rating	Buy	$42.00	Low
4/29/2020	Barclays	Boost Target	Equal Weight	$36.00 ➝ $37.00	Low
4/27/2020	Royal Bank of Canada	Reiterated Rating	Buy	$44.00	Medium
4/26/2020	Mizuho	Reiterated Rating	Buy	$42.00	High
4/2/2020	Morgan Stanley	Lower Target	Equal Weight	$43.00 ➝ $36.00	Medium
3/27/2020	Royal Bank of Canada	Lower Target	Outperform	$46.00 ➝ $44.00	Low
3/19/2020	Cantor Fitzgerald	Reiterated Rating	Buy	$53.00	High
3/18/2020	Mizuho	Reiterated Rating	Buy	$42.00	High
2/27/2020	Standpoint Research	Upgrade	Hold ➝ Buy		High
2/27/2020	Barclays	Initiated Coverage	Equal Weight	$36.00	Medium
2/5/2020	Mizuho	Initiated Coverage	Buy	$42.00	Low
1/29/2020	Cantor Fitzgerald	Reiterated Rating	Buy	$53.00	Low
1/28/2020	JPMorgan Chase & Co.	Reiterated Rating	Neutral	$37.00	Low
1/6/2020	Royal Bank of Canada	Initiated Coverage	Outperform	$46.00	Medium
11/6/2019	Credit Suisse Group	Reiterated Rating	Hold	$41.30	Low
10/29/2019	JPMorgan Chase & Co.	Reiterated Rating	Neutral		High
10/16/2019	Bank of America	Initiated Coverage	Neutral	$37.00	Low
9/19/2019	JPMorgan Chase & Co.	Boost Target	Neutral	$37.00 ➝ $46.00	Low
8/28/2019	DZ Bank	Upgrade	Sell ➝ Hold	$36.00	Medium
8/27/2019	Morgan Stanley	Lower Target	Equal Weight	$40.00 ➝ $38.00	High
8/27/2019	DZ Bank	Reiterated Rating	Hold ➝ Neutral		Medium
8/12/2019	Credit Suisse Group	Reiterated Rating	Hold ➝ Neutral		High
8/5/2019	UBS Group	Reiterated Rating	Neutral	$43.00	High
7/30/2019	Bank of America	Downgrade	Buy ➝ Neutral		High
7/30/2019	Morgan Stanley	Downgrade	Overweight ➝ Equal Weight	$48.00 ➝ $40.00	High
7/29/2019	JPMorgan Chase & Co.	Set Target	Neutral	$46.00	High
7/23/2019	JPMorgan Chase & Co.	Reiterated Rating	Neutral	$46.00	Low
7/15/2019	Credit Suisse Group	Initiated Coverage	Hold	$47.00	Low
6/17/2019	Credit Suisse Group	Reiterated Rating	Buy	$48.00	Low
6/17/2019	The Goldman Sachs Group	Reiterated Rating	Buy	$49.00	Low
6/17/2019	JPMorgan Chase & Co.	Reiterated Rating	Hold	$46.00	Low
6/4/2019	Morgan Stanley	Initiated Coverage	Overweight ➝ Overweight	$48.00	Low
5/28/2019	The Goldman Sachs Group	Initiated Coverage	Conviction-Buy		Low
5/9/2019	Barclays	Reiterated Rating	Hold	$41.00	Low
5/6/2019	Credit Suisse Group	Reiterated Rating	Buy	$48.00	Medium
4/30/2019	JPMorgan Chase & Co.	Set Target	Neutral	$46.00	Low

(Data available from 4/20/2019 forward)

News Sentiment Rating

0.66 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

40 very positive mentions
52 positive mentions
11 negative mentions
8 very negative mentions

Mentions as of

9/23/2023

58 very positive mentions
81 positive mentions
28 negative mentions
14 very negative mentions

Mentions as of

10/23/2023

28 very positive mentions
63 positive mentions
27 negative mentions
13 very negative mentions

Mentions as of

11/22/2023

58 very positive mentions
77 positive mentions
27 negative mentions
23 very negative mentions

Mentions as of

12/22/2023

48 very positive mentions
67 positive mentions
15 negative mentions
2 very negative mentions

Mentions as of

1/21/2024

71 very positive mentions
71 positive mentions
11 negative mentions
9 very negative mentions

Mentions as of

2/20/2024

80 very positive mentions
55 positive mentions
10 negative mentions
5 very negative mentions

Mentions as of

3/21/2024

72 very positive mentions
56 positive mentions
15 negative mentions
3 very negative mentions

Mentions as of

4/20/2024

Current Sentiment

Recent Stories by Sentiment

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Today's Range

Now: $26.00

$25.35

$26.00

50 Day Range

MA: $27.11

$25.39

$28.37

52 Week Range

Now: $26.00

$25.23

$40.37

Volume

38,372,801 shs

Average Volume

34,236,664 shs

Market Capitalization

$147.23 billion

P/E Ratio

72.22

Dividend Yield

6.62%

Beta

0.61

Frequently Asked Questions

What sell-side analysts currently cover shares of Pfizer?: The following Wall Street analysts have issued reports on Pfizer in the last twelve months: Argus, Bank of America Co., Barclays PLC, BMO Capital Markets, Cantor Fitzgerald, Citigroup Inc., Credit Suisse Group AG, Daiwa Capital Markets, Guggenheim, HSBC Holdings plc, Jefferies Financial Group Inc., JPMorgan Chase & Co., Morgan Stanley, StockNews.com, TD Cowen, TheStreet, Truist Financial Co., UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for PFE.
What is the current price target for Pfizer?: 16 Wall Street analysts have set twelve-month price targets for Pfizer in the last year. Their average twelve-month price target is $36.88, suggesting a possible upside of 41.8%. HSBC Holdings plc has the highest price target set, predicting PFE will reach $50.00 in the next twelve months. UBS Group AG has the lowest price target set, forecasting a price of $27.00 for Pfizer in the next year.
View the latest price targets for PFE.
What is the current consensus analyst rating for Pfizer?: Pfizer currently has 11 hold ratings and 6 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in PFE, but not buy more shares or sell existing shares.
View the latest ratings for PFE.
What other companies compete with Pfizer?: Other companies that are similar to Pfizer include Bristol-Myers Squibb, Zoetis, AbbVie, Merck & Co., Inc. and Johnson & Johnson. Learn More about companies similar to Pfizer.
How do I contact Pfizer's investor relations team?: Pfizer's physical mailing address is 235 EAST 42ND STREET, NEW YORK NY, 10017. The biopharmaceutical company's listed phone number is (212) 733-2323. The official website for Pfizer is www.pfizer.com. Learn More about contacing Pfizer investor relations.

Pfizer - PFE Stock Price Target and Predictions

Analyst Price Target for PFE

Current Consensus is Hold

Past Monthly Recommendations

Latest Recommendations

News Sentiment Rating

0.66 (Buy)

News Sentiment Over Time

Current Sentiment

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Pfizer?

What is the current price target for Pfizer?

What is the current consensus analyst rating for Pfizer?

What other companies compete with Pfizer?

How do I contact Pfizer's investor relations team?